Skip to main content
. 2017 May 2;8(32):52913–52922. doi: 10.18632/oncotarget.17577

Table 2. The sequences of primers used in this study.

Name Sequence
miR-106b RT 5′CTCAACTGGTGTCGTGGAGTCGGCAATTCAATCTGCACTGTCA 3′
Forward 5′ACACTCCAGCTGGGTGGCATAAAGTGCT 3′
Reverse 5′CTCAACTGGTGTCGTGGA 3′
Actin Forward 5′AGCCTCAAGATCATCAGCAATGCC 3′
Reverse 5′TGTGGTCATGAGTCCTTCCACGAT 3′
Zbtb7a Forward 5′ATCTGCGAGAAGGTCATCCA 3′
Reverse 5′CAGCAGCTGTCGCACTGGTA 3′
U6 Forward 5′’CTCGCTTCGGCAGCACA 3′
Reverse 5′AACGCTTCACGAATTTGCGT 3′